AbbVie’s $10.9 Billion Acquisition of Apogee Therapeutics: A Strategic Pivot in the Immunology Arms Race
SAN DIEGO — In a move that signals a significant intensification of the global battle for dominance in the immunology...
SAN DIEGO — In a move that signals a significant intensification of the global battle for dominance in the immunology...